Clin2
NCT07781085Worth exploringRecruiting

Radiation therapy after surgery for early glottic cancer

Early Stage Glottic Squamous Cell Carcinoma Involving the Anterior Commissure

This study looks at whether adding radiation therapy after surgery improves outcomes for people with early-stage glottic cancer that involves the anterior commissure (the front part of the vocal cords). If you join, you may receive radiation therapy or not, and the researchers will compare the results.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
38 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have a confirmed diagnosis of glottic squamous cell carcinoma (a type of throat cancer).
  • Your cancer is stage T1 or T2 and has not spread to lymph nodes or distant sites (N0M0).
  • You have undergone surgery to remove the cancer within the last 4 to 8 weeks, and the margins were negative (no cancer at the edges).
  • You have not received prior radiation therapy, chemotherapy, or other anti-cancer treatments.
  • You have an ECOG performance status of 0 or 1 (meaning you are fully active or restricted only in physically strenuous activity).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07781098Recruiting
Radiation therapy for early-stage voice box cancer with poor differentiation

This trial studies whether adding radiation therapy after surgery can help people with early-stage voice box cancer that has poor differentiation (cells look very abnormal). It aims to improve outcomes for this specific type of cancer.

Hangzhou, Zhejiang
NCT06306846Recruiting· Phase 2
Radiation and immunotherapy before surgery for head and neck cancer

This study tests giving a short course of targeted radiation (SBRT) along with immunotherapy and a targeted drug before surgery for advanced head and neck cancer. The goal is to see if this combination can shrink the tumor and improve outcomes.

Hangzhou, Zhejiang
NCT06957938Not yet recruiting· Phase 3
Chemotherapy with immunotherapy before surgery for advanced throat cancer

This trial tests adding an immunotherapy drug (PD-1 inhibitor) to chemotherapy before surgery for advanced laryngeal or hypopharyngeal cancer. The goal is to see if this combination shrinks tumors more and improves outcomes for patients who need their entire voice box removed.

Shanghai, Shanghai Municipality
NCT03358602Not yet recruiting
Radiation vs neck surgery for early supraglottic throat cancer

This study compares two ways to treat early supraglottic squamous-cell throat cancer: radiation therapy versus removing lymph node areas in the neck (neck dissection). It may help find which approach controls cancer while affecting quality of life as much as possible.

Tianjin, Tianjin Municipality
NCT07197060Not yet recruiting
Shorter radiation for early-stage glottic cancer

This study tests a shorter, higher-dose radiation schedule for people with early glottic cancer. It might mean fewer trips to the hospital and less burden on your voice box.

NCT06485778Recruiting· Phase 2
Radiation after surgery for early-stage oral tongue cancer

This trial tests whether giving radiation after surgery can lower the risk of the cancer coming back for people with oral tongue cancer that has specific high-risk features but not advanced spread. It aims to find the best treatment plan for patients with certain tumor characteristics.

Basking Ridge, New Jersey

Hear when a new Early Stage Glottic Squamous Cell Carcinoma Involving the Anterior Commissure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.